journal cover

Candida auris in Healthcare Facilities, New York, USA, 2013-2017

Emerging Infectious Diseases

Sep 19, 2018

Eleanor AdamsCandida auris Investigation Workgroup

Abstract

Candida auris is an emerging yeast that causes healthcare-associated infections. It can be misidentified by laboratories and often is resistant to antifungal medications. We describe an outbreak of C. auris infections in healthcare facilities in New York City, New York, USA. The investi...read more

Mentioned in this Paper

Corynebacterium auris
Antibiotics, Antifungal
Environment
Injection Fluconazole,200 MG Administered
Public Health Surveillance
Yeasts
Laboratory
Persons
Site
Sentinel Surveillance
39
13
3
50
Paper Details
References
  • References
  • Citations16
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations16
12

Feeds With Similar Papers

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Ebola Virus

Ebola Virus causes ebola virus disease, and is one of the deadliest pathogens known to man, with a mortality rate between 25-90% depending on the species and outbreak of ebola. Discover the latest research on Ebola Virus.

Emerging Infectious Diseases

Emerging Infectious Diseases are defined as those whose incidence in humans has increased in the past two decades or threaten to increase in the near future. Discover the latest research on Emerging Infectious Diseases.

Emerging Infectious Diseases (ASM)

Emerging Infectious Diseases are defined as those whose incidence in humans has increased in the past two decades or threaten to increase in the near future. Discover the latest research on Emerging Infectious Diseases.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaOctober 12, 2017
Sharon TsaySnigdha Vallabhaneni
Emerging Infectious Diseases

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris

Emerging Infectious DiseasesJanuary 19, 2017
Leighann SherryRiina Rautemaa-Richardson
© 2020 Meta ULC. All rights reserved

Candida auris in Healthcare Facilities, New York, USA, 2013-2017

Emerging Infectious Diseases

Sep 19, 2018

Eleanor AdamsCandida auris Investigation Workgroup

PMID: 30226155

DOI: 10.3201/eid2410.180649

Abstract

Candida auris is an emerging yeast that causes healthcare-associated infections. It can be misidentified by laboratories and often is resistant to antifungal medications. We describe an outbreak of C. auris infections in healthcare facilities in New York City, New York, USA. The investi...read more

Mentioned in this Paper

Corynebacterium auris
Antibiotics, Antifungal
Environment
Injection Fluconazole,200 MG Administered
Public Health Surveillance
Yeasts
Laboratory
Persons
Site
Sentinel Surveillance
39
13
3
50

Feeds With Similar Papers

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaOctober 12, 2017
Sharon TsaySnigdha Vallabhaneni
Emerging Infectious Diseases

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris

Emerging Infectious DiseasesJanuary 19, 2017
Leighann SherryRiina Rautemaa-Richardson
Paper Details
References
  • References
  • Citations16
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations16
12

Download from

Publisher
PubMed
/papers/candida-auris-in-healthcare-facilities-new-york/30226155